Literature DB >> 33147708

Aortic Prosthesis-Associated MDR Pseudomonas Infections as a Diagnostic and Therapeutic Challenge.

Rita Filipe1,2, Filipa Ceia1,2, Ana Cláudia Carvalho1, Margarida Tavares1,3, José Teixeira4, António Sarmento1,2.   

Abstract

Endovascular prostheses are used to treat life-threatening conditions such as ruptured aortic aneurysms. Prosthetic infection cause significant morbidity and mortality, posing important diagnostic and therapeutic challenges. It is particularly difficult to diagnose and, in the era of multidrug resistance (MDR), these type of infections may become even more difficult to treat. Herein, we reported a case of a secondary prosthetic endovascular infection following repeated bacteremia episodes from a urinary source. This case illustrates an MDR Pseudomonas aeruginosa aortic infection that was difficult to diagnose with no oral antibiotic treatment options.

Entities:  

Keywords:  MDR Pseudomonas; PET scan; aortic prosthesis infection; axilobifemoral revascularization

Year:  2020        PMID: 33147708      PMCID: PMC7768536          DOI: 10.3390/idr12030012

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  11 in total

1.  Long-term home-based parenteral antibiotic treatment of a prosthetic vascular graft infection caused by Pseudomonas aeruginosa.

Authors:  Steen Terpling; Carsten Schade Larsen; Henrik C Schønheyder
Journal:  Scand J Infect Dis       Date:  2006

2.  Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses.

Authors:  M Spacek; O Belohlavek; J Votrubova; P Sebesta; P Stadler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-24       Impact factor: 9.236

Review 3.  Management of aortic graft infections - the present strategy and future perspectives.

Authors:  V Treska; B Certik; J Molacek
Journal:  Bratisl Lek Listy       Date:  2016       Impact factor: 1.278

4.  Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.

Authors:  J M Seeger; H A Pretus; M B Welborn; C K Ozaki; T C Flynn; T S Huber
Journal:  J Vasc Surg       Date:  2000-09       Impact factor: 4.268

5.  The relevance of aortic endograft prosthetic infection.

Authors:  Paul Cernohorsky; Michel M P J Reijnen; Ignace F J Tielliu; Steven M M van Sterkenburg; Jan J A M van den Dungen; Clark J Zeebregts
Journal:  J Vasc Surg       Date:  2011-03-11       Impact factor: 4.268

6.  Are gram-negative bacteria a contraindication to selective preservation of infected prosthetic arterial grafts?

Authors:  K D Calligaro; F J Veith; M L Schwartz; R P Savarese; D A DeLaurentis
Journal:  J Vasc Surg       Date:  1992-09       Impact factor: 4.268

7.  Treatment and outcomes of aortic endograft infection.

Authors:  Matthew R Smeds; Audra A Duncan; Michael P Harlander-Locke; Peter F Lawrence; Sean Lyden; Javariah Fatima; Mark K Eskandari
Journal:  J Vasc Surg       Date:  2016-02       Impact factor: 4.268

8.  Aorto-femoral graft infections: a clinical and microbiological analysis.

Authors:  C Santini; P Baiocchi; M Venditti; C Brandimarte; A Tarasi; L Rizzo; F Speziale; P Fiorani; P Serra
Journal:  J Infect       Date:  1993-07       Impact factor: 6.072

9.  The incidence and factors associated with graft infection after aortic aneurysm repair.

Authors:  Todd R Vogel; Rebecca Symons; David R Flum
Journal:  J Vasc Surg       Date:  2008-02       Impact factor: 4.268

10.  Intra-abdominal aortic graft infection: prognostic factors associated with in-hospital mortality.

Authors:  Matthias Garot; Pierre-Yves Delannoy; Agnès Meybeck; Béatrice Sarraz-Bournet; PierVito d'Elia; Thibaud d'Escrivan; Patrick Devos; Olivier Leroy
Journal:  BMC Infect Dis       Date:  2014-04-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.